A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats

We newly developed a hybrid protein, tentatively named rMIKO-1, using gene technology. We herein investigated the effects of rMIKO-1 on activated macrophages and discussed its potential as a suppressor of experimental colitis. Fluorescent microscopy was used to observe the dynamic mobility of rMIKO-...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Kohki, Ikemoto, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502114/
https://www.ncbi.nlm.nih.gov/pubmed/34628574
http://dx.doi.org/10.1007/s10753-021-01537-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502114/
https://www.ncbi.nlm.nih.gov/pubmed/34628574
http://dx.doi.org/10.1007/s10753-021-01537-5

Ejemplares similares